Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Schreiber

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Seminars in Dialysis|August 4, 2005
Common misconceptions about levocarnitine and dialysisBrian Schreiber
Nephrology News & Issues|April 29, 2003
CMS national coverage decision for L-carnitine injection--a reasonable processBrian Schreiber
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 7, 2005
Levocarnitine and dialysis: a reviewBrian Schreiber
Seminars in Dialysis|March 5, 2002
Safety of oral carnitine in dialysis patientsBrian Schreiber
The Journal of Clinical Psychiatry|June 30, 2005
Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional studyFrancisco A Moreno, Helen Macey, Brian Schreiber
Leukemia & Lymphoma|September 20, 2016
Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection - a reviewLynda Kwon Beaupin, Bruce Bostrom, Matthew J Barth, et al.
American Journal of Nephrology|April 2, 2005
Carnitine therapy is associated with decreased hospital utilization among hemodialysis patientsWaqar H Kazmi, Gregorio T Obrador, Maya Sternberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2020
Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic SclerosisYun Zhang, Honglin Zhu, Florian Layritz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Seminars in Dialysis|August 4, 2005
Common misconceptions about levocarnitine and dialysisBrian Schreiber
Nephrology News & Issues|April 29, 2003
CMS national coverage decision for L-carnitine injection--a reasonable processBrian Schreiber
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 7, 2005
Levocarnitine and dialysis: a reviewBrian Schreiber
Seminars in Dialysis|March 5, 2002
Safety of oral carnitine in dialysis patientsBrian Schreiber
The Journal of Clinical Psychiatry|June 30, 2005
Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional studyFrancisco A Moreno, Helen Macey, Brian Schreiber
Leukemia & Lymphoma|September 20, 2016
Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection - a reviewLynda Kwon Beaupin, Bruce Bostrom, Matthew J Barth, et al.
American Journal of Nephrology|April 2, 2005
Carnitine therapy is associated with decreased hospital utilization among hemodialysis patientsWaqar H Kazmi, Gregorio T Obrador, Maya Sternberg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2020
Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic SclerosisYun Zhang, Honglin Zhu, Florian Layritz, et al.
Pageof 1